Extracellular vesicle (EV) purification is an essential first step before downstream characterisation and functional studies. Biological samples contain abundant soluble proteins, lipoproteins and other nanoparticles that can interfere with EV analysis, making effective purification critical for generating reliable data.

Why is EV isolation important?

EVs are released into complex biological fluids and cell culture media alongside a wide range of contaminants that may interfere with downstream analysis.

Depending on the sample type, these contaminants can include:

  • Soluble proteins
  • Protein aggregates
  • Lipoproteins
  • Cell debris
  • Free nucleic acids

Without effective purification, these contaminants may reduce assay sensitivity, interfere with molecular analyses or contribute to misleading experimental results.

Method

Principle

EV Recovery

Purity / Specificity

Key Considerations

Size exclusion chromatography (SEC)

Size

High

Moderate-High

Gentle; good balance of recovery and purity; similarly sized particles may co-isolate

Differential ultracentrifugation (dUC)

Size / density / sedimentation

Moderate

Moderate

Widely established; time-consuming; requires specialist equipment; may co-isolate non-EV particles

Density gradient centrifugation

Density

Low-Moderate

High

High purity but lengthy, technically demanding and typically lower throughput

Polymer precipitation

Solubility / precipitation

High

Low

Simple and accessible, but co-precipitates proteins and other non-EV particles

Ultrafiltration / TFF

Size

High

Low-Moderate

Rapid and scalable; particularly useful for concentration; recovery can be affected by membrane adsorption

Immunoaffinity capture

EV surface markers

Low-Moderate

High*

Enables enrichment of selected EV populations but recovery is restricted to EVs expressing the target marker

*Recovery and specificity relate to the targeted EV population and depend on the selected marker.

Among commonly used approaches, SEC offers a useful compromise between EV recovery and purity while providing gentle, size-based separation.

Principles and limitations of SEC

Size exclusion chromatography (SEC) separates particles according to their size as they pass through a porous stationary phase.

Larger particles, such as EVs, are excluded from the pores of the stationary phase and therefore elute first. Smaller molecules, including soluble proteins and other low molecular weight contaminants, enter the pores and are retained for longer, allowing them to be separated from the EV-containing fraction.

SEC provides a good compromise between EV purity and particle recovery, while avoiding the high centrifugal forces or chemical precipitation used by some alternative isolation methods. It has therefore become a widely used approach for EV isolation and purification (Böing et al., 2014).

However, SEC separates particles primarily according to size and cannot efficiently separate EVs from similarly sized particles. This is particularly relevant for complex biofluids such as plasma, where lipoproteins overlap with EVs in size and may co-isolate during SEC. Additional purification steps may therefore be required depending on the sample type and downstream application.

SEC separates particles based on size as they pass through a porous stationary phase. Larger particles elute first, while smaller molecules enter the pores and are retained for longer.

From Gravity-SEC to Spin-SEC

Traditional gravity-fed SEC relies on gravity flow and the collection of multiple fractions, making purification relatively slow and requiring multiple manual handling steps.

Vesi-SEC uses a spin-SEC approach, combining size-based separation with centrifugal processing to simplify and accelerate purification. EVs can be purified in as little as one minute, without fraction collection or sample dilution, while maintaining high particle recovery (>90%).

The Vesi-SEC platform is scalable from individual Micro and Midi columns to 96-well processing, enabling rapid spin-SEC purification across different sample volumes and throughput requirements.

Figure 1: Schematic of Vesi-SEC workflow for EV isolation (top). Nanoparticle recovery efficiency, as measured by Interferometric Light Microscopy (ILM) (VideoDrop, Myriade).

How can EVs be isolated from cell culture media?

Conditioned cell culture media contains EVs alongside soluble proteins, free nucleic acids and other cell culture components that can interfere with downstream analysis.

A typical EV isolation workflow begins with pre-clearing to remove cells and larger cell debris by low-speed centrifugation. Concentration of the conditioned media (e.g. by ultrafiltration) is optional but may be beneficial when working with dilute samples or larger starting volumes. Vesi-SEC is then used to rapidly separate EVs from the remaining soluble contaminants, generating purified EV preparations suitable for downstream applications.

How can EVs be isolated from plasma?

Plasma presents additional purification challenges because it contains abundant lipoproteins that overlap with EVs in both size and density. SEC alone cannot completely separate these particle populations.

For plasma EV isolation, Vesi-Omics provides a convenient all-in-one kit containing both the lipoprotein depletion reagent and Vesi-SEC columns required for the two-step workflow.

Vesi-Omics reagent selectively depletes low-density lipoproteins (LDL), reducing one of the major contaminating particle populations present in plasma. Next, Vesi-SEC removes remaining soluble proteins, HDL and other low molecular weight contaminants, producing purified EVs ready for downstream analysis.

Figure 2. Vesi-Omics depletes plasma contaminants while retaining EV-associated markers. A) Total protein concentration is substantially reduced following the Vesi-Omics workflow, with 78.2% and 87.2% protein depletion observed using Vesi-SEC Midi and Micro formats, respectively, as measured by BCA assay. B) Dot blot analysis demonstrates depletion of the lipoprotein marker LDL following Vesi-Omics treatment, alongside retention of the EV-associated tetraspanin CD63.
Learn more about Vesi-Omics

Practical tips for successful EV purification

  • Remove cells and large debris before SEC.
  • Avoid overloading the column.
  • Use 0.22 μm-filtered buffers throughout the workflow to minimise particulate contamination
    Select the appropriate Vesi-SEC format based on sample volume.
  • For plasma samples, use Vesi-Omics, a complete purification kit combining lipoprotein depletion with Vesi-SEC to improve EV purity.
  • Store purified EVs under appropriate conditions to preserve sample integrity. (Explore Vesi-Safe for long-term storage of precious EV samples.)

Products

Sample Volume

Typical Applications

50–100 μL

Analytical purification, small-volume EV isolation, fluorescent sample clean-up

0.5–1 mL

Larger-volume EV purification, viral vectors, liposomes, LNPs

50–100 μL

High-throughput purification workflows